Search Results - "DE BOER, Antonius" :: K.UTB vyhledávací portál

Regulatory scientific advice on non-inferiority drug trials

by Wangge, Grace, Putzeist, Michelle, Knol, Mirjam J, Klungel, Olaf H, Gispen-De Wied, Christine C, de Boer, Antonius, Hoes, Arno W, Leufkens, Hubert G, Mantel-Teeuwisse, Aukje K
Published in PloS one (05.09.2013)

Get full text

Journal Article

Loading…

The Effect of Eighteen-Month Metformin Treatment in Obese Adolescents: Comparison of Results Obtained in Daily Practice with Results from a Clinical Trial

by Knibbe, C. A. J., de Boer, A., van de Garde, Ewoudt M. W., Hoving, Vera, van der Aa, M. P., van der Vorst, M. M. J.
Published in Journal of Obesity (01.01.2016)

Get full text

Journal Article

Loading…

Challenges of defining a non-inferiority margin: a case study of non-inferiority randomized controlled trials of oral anti-thrombolytic agents for prophylaxis of venous thromboembolic events after orthopedic surgery

by Wangge, Grace, Klungel, Olaf H, Roes, Kit CB, de Boer, Antonius, Hoes, Arno W, Knol, Mirjam J
Published in Current controlled trials in cardiovascular medicine (13.12.2011)

Get full text

Journal Article

Loading…

The trade-off between cardiovascular and gastrointestinal effects of rofecoxib

by Florentinus, Stefan R., Heerdink, Eibert R., Boer, Antonius de, van Dijk, Liset, Leufkens, Hubert G. M.
Published in Pharmacoepidemiology and drug safety (01.07.2005)

Get full text

Journal Article

Loading…

$Methodological comparison of marginal structural model, time-varying Cox regression, and propensity score methods: the example of antidepressant use and the risk of hip fracture$

Methodological comparison of marginal structural model, time-varying Cox regression, and propensity score methods: the example of antidepressant use and the risk of hip fracture

by Ali, M. Sanni, Groenwold, Rolf H. H., Belitser, Svetlana V., Souverein, Patrick C., Martín, Elisa, Gatto, Nicolle M., Huerta, Consuelo, Gardarsdottir, Helga, Roes, Kit C. B., Hoes, Arno W., de Boer, Antonius, Klungel, Olaf H.
Published in Pharmacoepidemiology and drug safety (01.03.2016)

Get full text

Journal Article

Loading…

Differences in interaction and subgroup-specific effects were observed between randomized and nonrandomized studies in three empirical examples

by Schmidt, Amand F, Rovers, Maroeska M, Klungel, Olaf H, Hoes, Arno W, Knol, Mirjam J, Nielen, Mirjam, de Boer, Antonius, Groenwold, Rolf H.H
Published in Journal of clinical epidemiology (01.06.2013)

Get full text

Journal Article

Loading…

Drug costs associated with non-adherence to cholesterol management guidelines for primary prevention of cardiovascular disease in an elderly population : The Rotterdam Study

by GUMBS, Pearl D, VERSCHUREN, W. M. Monique, MANTEL-TEEUWISSE, Aukje K, DE WIT, Ardine G, HOFMAN, Albert, TRIENEKENS, Paul H, STRICKER, Bruno H. Ch, DE BOER, Antonius, KLUNGEL, Olaf H
Published in Drugs & aging (01.01.2006)

Get full text

Journal Article

Loading…

The trade-off between cardiovascular and gastrointestinal effects of rofecoxib

by Florentinus, Stefan R., Heerdink, Eibert R., Boer, Antonius de, van Dijk, Liset, Leufkens, Hubert G.M.
Published in Pharmacoepidemiology and drug safety (01.09.2005)

Get full text

Journal Article